The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is issuing a Request for Information (RFI) to identify pharmaceutical manufacturers willing to participate in a voluntary labeling pilot. The pilot aims to add product labeling data specifying the country of origin for the Finished Dose Form (FDF), each Active Pharmaceutical Ingredient (API), and each Key Starting Material (KSM), potentially via QR codes or other accessible methods. DLA is seeking industry feedback on operational feasibility, including the ability to provide lot-specific sourcing information, existing traceability systems, and the estimated effort and cost impacts of implementation. Interested manufacturers are invited to submit a written response describing their products, willingness to participate, and any concerns or recommendations for structuring the pilot. This RFI is for information and planning purposes only and does not constitute a solicitation.